DML Stage 3
1 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| LUTEIN BY SCLERAL IONTOPHORESIS IN PATIENTS WITH STAGE 3 AGE-RELATED MACULAR DEGENERATION (AMD) (NCT06465342) | OFFHEALTH S.p.A. | 2024-06-12 |
Track DML Stage 3 automatically
Every clearance here is in the API, with alerts when new ones post.